NSFDC showcases success in bolstering entrepreneurship amongst depressed classes (See 'Corp Brief') Govt reviews BSNL performance for Q1 FY 2026-27 (See 'Corp Brief') India enters next phase of governance transformation with AI-driven administrative reforms: MoS (See 'Corp Brief') IPR - If infringing use is coupled alleged fraudulent online payment & earning schemes, conduct may be treated not merely as trademark infringement and passing off, but also as phishing & cyber fraud justifying urgent intervention: HC (See 'Legal Desk') MeitY releases 2nd edition of the Digital Threat Report 2025-26 for BFSI Sector (See 'Corp Brief') On Eve of Bharat Tex 2026, India prepares to host World's Largest Global Textiles Expo (See 'Corp Brief') IPR - In vitro screening method functions as diagnostic process, which is barred from patentability u/s 3(i) of Patents Act: HC (See 'Legal Desk') 'SANKALP' to guide CPWD's Journey towards Future-Ready Organisation: Union Minister (See 'Corp Brief') Healthcare facilities worth Rs 668 Crore to benefit 53 Lakh ESI Beneficiaries (See 'Corp Brief') Chouhan gives message of Green India during dialogue with Vriksh Mitra (See 'Corp Brief') IPR - If on visual comparison, rival medicinal marks are strikingly similar in essential features, overall get up and packaging, and where trade channels and consumer base are common, likelihood of deception is sufficient to justify interim injunction: HC (See 'Legal Desk') Lakhanpur among first towns selected under PM SVANidhi 'Street Food Hub' Plan: MoS (See 'Corp Brief') Paswan hails PMFME Scheme's landmark achievement of 2 lakh Credit-Linked Beneficiaries (See 'Corp Brief') 500 officials participate in inaugural webinar on Anemia and Adolescent Health (See 'Corp Brief') IPR - Purpose of summary judgment in commercial suits is to ensure time-bound disposal and that trial is not default norm: HC (See 'Legal Desk') Ministry of Textiles to organise 'Weave The Future 4.0 - Upcycling Edition' at Dilli Haat (See 'Corp Brief') IPR - For purposes of Sec 57 of Trade Marks Act, foreign proprietor may succeed in rectification by proving that its mark had acquired actionable recognition, even without formal commercial launch or direct sales: HC (See 'Legal Desk') Nadda chairs Steering Group Meeting of Ayushman Bharat Digital Mission (See 'Corp Brief') DoP and TRAI to conduct Village-Level Telecom Network Performance Survey (See 'Corp Brief') IBC - Demand notice in Form B under Rule 7(1) of Personal Guarantor Rules is only procedural requirement prior to filing and does not amount to invocation of guarantee: NCLT (See 'Legal Desk') Tech Innovation and disruption in Construction Industry (See 'CORP EINSICHT')

Print

MoS reaffirms India's commitment to global pharmaceutical standardization

Published: Feb 06, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 06, 2025: UNION Minister of State for Health and Family Welfare, Anupriya Patel delivered the keynote address at the 15th International Meeting of World Pharmacopoeias (IMWP), hosted by the Indian Pharmacopoeia Commission (IPC) under the aegis of the Ministry of Health and Family Welfare, Government of India, in collaboration with the World Health Organization (WHO), here today. The meeting brought together global pharmacopoeial leaders, regulatory authorities, and industry stakeholders to deliberate on key issues related to pharmaceutical standards and harmonization.

Addressing the gathering, Patel reaffirmed India's commitment to global pharmaceutical standardization and regulatory convergence. She highlighted India's role as the "Pharmacy of the World" and emphasized the importance of ensuring access to high-quality medicines globally. She stated that the IMWP serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization.

On this occasion, the Union Minister also released the IPC Newsletter 2024 and a special IPC video film, which showcase India's advancements in pharmacopoeial science and the Commission's efforts in ensuring high-quality pharmaceutical standards. The video film can be accessed at the following link: https://www.youtube.com/watch?v=MCdAZodvOSM .

Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare, underscored the significance of global partnerships in strengthening pharmaceutical quality standards. She reiterated India's efforts in aligning regulatory frameworks with international best practices and ensuring the availability of safe and effective medicines worldwide.

Dr. Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, IPC, and Drugs Controller General (India), highlighted IPC's contributions in setting global benchmarks in pharmacopoeial science. He elaborated on IPC's initiatives, including the IP Online platform, which enhances accessibility and usability of Indian Pharmacopoeia standards. He emphasized the role of scientific advancements and regulatory cooperation in shaping global pharmaceutical standards.

Dr. Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasized the importance of regulatory harmonization in ensuring patient safety and public health.

The 15th IMWP is set to facilitate discussions on key focus areas, including:

- Updates on recommendations from the 14th IMWP and review of progress on harmonization initiatives.

- Emerging issues in impurity assessment (Q3) and the implications of ICH Q6 guidelines on pharmacopoeial monograph specifications.

- Defining the IMWP Charter to establish a long-term governance structure for the forum.

- Enhancing collaboration among global pharmacopoeias and regulatory bodies, with updates from the Pharmacopoeial Discussion Group (PDG).

- Promotion of environmental sustainability in pharmacopoeial practices and pharmaceutical manufacturing standards.

- Finalization of reports for the 15th IMWP and preparatory discussions for the 16th IMWP.

The deliberations during the IMWP will reinforce the role of pharmacopoeias in ensuring the quality, safety, and efficacy of medicines. The outcomes of the meeting will guide future collaborations in standard-setting and regulatory harmonization.

The 15th IMWP, which commenced today, will conclude on 7th February 2025. The discussions held over these three days will set the stage for further strengthening global pharmacopoeial cooperation and enhancing pharmaceutical quality assurance.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.